User:Mr. Ibrahem/Rizatriptan

Rizatriptan, sold under the brand name Maxalt among others, is a medication used for the treatment of migraine headaches. It should be used as soon as the headache starts. It is taken by mouth.

Common side effects include chest pain, dizziness, dry mouth, and tingling. Other side effects may include myocardial infarction, stroke, high blood pressure, serotonin syndrome, and anaphylaxis. Excessive use may result in medication overuse headaches. Use is not recommended during pregnancy and breastfeeding is not recommended within 24 hours after taking a dose. Rizatriptan is in the triptan class and is believed to work by activating the 5-HT1 receptor.

Rizatriptan was patented in 1991 and came into medical use in 1998. It is available as a generic medication. A dose in the United Kingdom costs the NHS about 3.10 £ as of 2019. In the United States the wholesale cost of this amount is about US$0.73. In 2017, it was the 204th most commonly prescribed medication in the United States, with more than two million prescriptions.